Coca Cola Q2 2026 Earnings
Unit Case Volume +5% (est +2.47%) -Comparable EPS 97C (est 93C) -Comp Oper Margin 35.6% (Est. 35%) -Adj. Organic Rev. +6% (est +3.63%) -Concentrate Sales +4% (est +1.04%) -Price/Mix +2% (est +2.61%) -Sees FY Comparable EPS +9% TO +10%, SAW +4% TO 5% (est 4.64%)
Story updates
11:09:21 AM UTC
SquawkNews
Coca Cola Q2 2026 Earnings
11:10:27 AM UTC
SquawkNews
Paypal Q2 2026 Earnings
11:12:24 AM UTC
SquawkNews
Core Sales $4.74B (est $4.65B) -Core EPS 78C (est 76C) -Sees Q3 Core EPS 85C to 89C (est 86C) -Sees Q3 Core Sales $4.9B To $5B (est $5B)
11:17:18 AM UTC
SquawkNews
GSK Q2 2026 Earnings
8P) -Rev. 1B) -SHINGRIX Rev. 8M) -AREXWY REV. 8M) -Expect 20+ Phase III Trial Starts In 2026 -On Track For 2031 Sales Outlook Of Over 40B -2026 Guidance Reaffirmed